Cargando…

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care

OBJECTIVE: To compare rates of performing National Institute for Health and Care Excellence-recommended health checks and prescribing in people with type 2 diabetes (T2D), before and after the first COVID-19 peak in March 2020, and to assess whether trends varied by age, sex, ethnicity and deprivati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carr, Matthew J, Wright, Alison K, Leelarathna, Lalantha, Thabit, Hood, Milne, Nicola, Kanumilli, Naresh, Ashcroft, Darren M, Rutter, Martin K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520602/ https://www.ncbi.nlm.nih.gov/pubmed/34642228 http://dx.doi.org/10.1136/bmjqs-2021-013613

Ejemplares similares

Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK
por: Carr, Matthew J, et al.
Publicado: (2021)

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot
por: Thabit, Hood, et al.
Publicado: (2016)

COVID-19: Impact of and on Diabetes
por: Schofield, Jonathan, et al.
Publicado: (2020)

Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England
por: Prabhu Navis, Joshi, et al.
Publicado: (2020)

Real-World Outcomes of Glucose Sensor Use in Type 1 Diabetes—Findings from a Large UK Centre
por: Lee, Kyuhan, et al.
Publicado: (2021)

Impact of the CamAPS FX hybrid closed‐loop insulin delivery system on sleep traits in older adults with type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2022)

Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
por: Hovorka, Roman, et al.
Publicado: (2014)

Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents
por: Barnard, Katharine D, et al.
Publicado: (2014)

Risk factor control and outpatient attendance in young adults with diabetes
por: Nadeem, F., et al.
Publicado: (2018)

Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study
por: Boughton, Charlotte K, et al.
Publicado: (2022)

Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data
por: Zghebi, Salwa S, et al.
Publicado: (2020)

Digital Interventions Supporting Self-care in People With Type 2 Diabetes Across Greater Manchester (Greater Manchester Diabetes My Way): Protocol for a Mixed Methods Evaluation
por: Goldthorpe, Joanna, et al.
Publicado: (2022)

Glycaemic variability: The under‐recognized therapeutic target in type 1 diabetes care
por: Wilmot, Emma G., et al.
Publicado: (2019)

Hyperglycemia and Death in Cystic Fibrosis–Related Diabetes
por: Adler, Amanda I., et al.
Publicado: (2011)

Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes
por: Kanumilli, Naresh, et al.
Publicado: (2023)

Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2018)

The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective
por: Leelarathna, Lalantha, et al.
Publicado: (2018)

Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes
por: Emami, Ali, et al.
Publicado: (2017)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol
por: Leelarathna, Lalantha, et al.
Publicado: (2014)

Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA(1c) and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes
por: Wright, Alison K., et al.
Publicado: (2020)

Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings
por: Wright, Alison K., et al.
Publicado: (2020)

The impact of using a closed‐loop system on food choices and eating practices among people with Type 1 diabetes: a qualitative study involving adults, teenagers and parents
por: Lawton, J., et al.
Publicado: (2019)

Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study
por: Lawton, Julia, et al.
Publicado: (2019)

Predictors of heart failure development in type 2 diabetes: a practical approach
por: Verma, Subodh, et al.
Publicado: (2019)

Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes
por: Tauschmann, Martin, et al.
Publicado: (2015)

SAT-618 Nattokinase to Improve Insulin Sensitivity and Weight Loss in Women with Obesity +/- Diabetes
por: Cobos, Leopoldo M, et al.
Publicado: (2020)

Coming of age: the artificial pancreas for type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2016)

Risk factors for self-harm in people with epilepsy
por: Gorton, Hayley C., et al.
Publicado: (2018)

Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial
por: Leelarathna, Lalantha, et al.
Publicado: (2013)

Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study
por: Ajabnoor, Alyaa M., et al.
Publicado: (2022)

Improving the quality of insulin prescribing for people with diabetes being discharged from hospital
por: Bain, Amie, et al.
Publicado: (2019)

Drug prescribing during the last year of life in very old people with diabetes
por: Hamada, Shota, et al.
Publicado: (2017)

Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study
por: Manski-Nankervis, Jo-Anne, et al.
Publicado: (2019)

S163. FEASIBILITY STUDY: MEASURES OF SLEEP AND PHYSICAL ACTIVITY IN PEOPLE WITH SCHIZOPHRENIA
por: Berry, Alexandra, et al.
Publicado: (2018)

Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist
por: Bally, Lia, et al.
Publicado: (2017)

Trends in HbA1c and other biochemical outcomes of individuals with newly diagnosed type 1 diabetes
por: O’Carroll-Lolait, A., et al.
Publicado: (2020)

Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association
por: Young-Hyman, Deborah, et al.
Publicado: (2016)

An evaluation of the performance of the NHS Health Check programme in identifying people at high risk of developing type 2 diabetes
por: Smith, Sarah, et al.
Publicado: (2013)

MON-618 A Framework for Understanding and Managing ‘The Diabetes Syndrome’: A Unified Pathophysiologic Approaching the Context of the Beta-Cell Classification of Diabetes
por: Schwartz, Stanley S
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rqlgg29ouq33c9h64ardg1mok7